Based on the existing data, and to the best of my understanding of having read every paper, authorization application and preprint on the efficacy of these vaccines, I can, without a hesitation, say that of the ones I know are being considered in various places in the US, UK and Europe—Moderna, Pfizer/BioNTech, J&J, Oxford/AstraZeneca, Novavax—I would be happy with receiving *any* of them. I would easily recommend *any* of them to anyone I know, whatever they were offered. (I have not yet read the Sputnik paper, but the numbers look excellent. I know there are issues of trust there, but I don’t have any a priori reason to think that it also wouldn’t work well). If we were to find real efficacy differences, we’d give the higher efficacy ones to the elderly (whose immune systems tend to work less well). But, as a country, and as the world, as things stand, all of these vaccines will do the job of eventually getting us out of this pandemic—once enough people are vaccinated.